<DOC>
	<DOCNO>NCT00046423</DOCNO>
	<brief_summary>This trial treat patient advance ( metastatic ) cancer new chemotherapeutic agent may readily tolerate standard therapy . Patients give new chemotherapeutic medicine week , intravenous route , three week , follow rest week . Treatment repeat four week cycle patient improves therapy , adverse event require withdrawal medication .</brief_summary>
	<brief_title>A Trial ABI-007 Patients With Advanced Non-Hematologic Malignancies</brief_title>
	<detailed_description>This dose-escalating study . ABI-007 administer outpatient infusion three week follow week rest . The treatment course repeat every 28 day . No pretreatment normally consider necessary . Patients white blood cell platelet count monitored indication performance ( Karnofsky Performance Status ) , ask describe adverse event , present . Patients treat minimum two cycle evaluable study , may continue study four cycle within study , tumor response safety parameter warrant continue . Patients may continue study medication beyond investigator 's discretion .</detailed_description>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<criteria>At least 18 year age Life expectancy least 2 month Off therapy least 3 week prior study drug administration Biopsyproven diagnosis advance malignancy Patients solid tumor fail standard therapy Karnofsky Performance Status 70 % 02 SWOG Performance Status Hemoglobin least 9 White Blood Cell count least 3000/mm3 absolute neutrophil count least 1500/mm3 Platelet count least 100,000/mm3 Serum Creatinine le 2 mg/dL Transaminases le 3X upper limit normal Patient must provide informed consent Serum Bilirubin le 1.5 mg/dL</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Cancer</keyword>
	<keyword>solid tumor</keyword>
	<keyword>Advanced malignancy</keyword>
	<keyword>Taxane therapy</keyword>
	<keyword>Biopsy-proven diagnosis advance malignancy</keyword>
	<keyword>Various solid tumor refractory</keyword>
</DOC>